Total Payments
$3,851
2024 Payments
$686.98
Companies
22
Transactions
156
Medicare Patients
1,187
Medicare Billing
$90,775
Payment Breakdown by Category
Food & Beverage$3,752 (97.4%)
Education$99.00 (2.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,752 | 155 | 97.4% |
| Education | $99.00 | 1 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $749.08 | 88 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $604.87 | 7 | $0 (2024) |
| GlaxoSmithKline, LLC. | $368.56 | 8 | $0 (2024) |
| Astellas Pharma US Inc | $355.21 | 17 | $0 (2023) |
| PFIZER INC. | $236.88 | 4 | $0 (2024) |
| Allergan Inc. | $218.16 | 2 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $209.42 | 2 | $0 (2023) |
| Nestle HealthCare Nutrition Inc. | $208.98 | 2 | $0 (2022) |
| Daiichi Sankyo Inc. | $157.53 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $110.33 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $686.98 | 19 | GlaxoSmithKline, LLC. ($223.90) |
| 2023 | $381.36 | 8 | E.R. Squibb & Sons, L.L.C. ($118.16) |
| 2022 | $543.67 | 12 | GlaxoSmithKline, LLC. ($124.96) |
| 2021 | $401.01 | 8 | Novo Nordisk Inc ($117.43) |
| 2020 | $242.37 | 24 | Novo Nordisk Inc ($140.21) |
| 2019 | $513.55 | 71 | Novo Nordisk Inc ($325.06) |
| 2018 | $107.82 | 3 | Allergan Inc. ($71.28) |
| 2017 | $974.08 | 11 | AstraZeneca Pharmaceuticals LP ($385.12) |
All Payment Transactions
156 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $112.95 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/24/2024 | Organogenesis Inc. | PURAPLY WOUND MATRIX (Device) | Food and Beverage | In-kind items and services | $104.01 | General |
| Category: WOUND CARE | ||||||
| 10/14/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $102.30 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Gastroenterology | ||||||
| 09/17/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: RESPIRATORY | ||||||
| 09/11/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/05/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $8.51 | General |
| Category: Iron Deficiency Anemia | ||||||
| 07/30/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $6.89 | General |
| Category: Iron Deficiency Anemia | ||||||
| 07/16/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: VACCINE | ||||||
| 06/10/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $7.58 | General |
| Category: Iron Deficiency Anemia | ||||||
| 06/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: RESPIRATORY | ||||||
| 06/03/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $8.25 | General |
| Category: Iron Deficiency Anemia | ||||||
| 05/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $7.18 | General |
| Category: RESPIRATORY | ||||||
| 04/09/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: VACCINES | ||||||
| 03/21/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $69.24 | General |
| Category: RESPIRATORY | ||||||
| 02/20/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Diabetes | ||||||
| 02/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Obesity | ||||||
| 01/17/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $103.88 | General |
| Category: Rare Disease | ||||||
| 12/19/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: DIABETES | ||||||
| 12/18/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Gastroenterology | ||||||
| 12/11/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $118.16 | General |
| Category: Cardiovascular | ||||||
| 11/13/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Iron Deficiency Anemia | ||||||
| 07/24/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $94.81 | General |
| Category: Heart Failure | ||||||
| 06/27/2023 | Medtronic, Inc. | CONTOUR 3D (Device) | Food and Beverage | In-kind items and services | $85.00 | General |
| Category: Heart Valves | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 205 | 243 | $51,642 | $19,379 |
| 2022 | 8 | 256 | 312 | $52,985 | $20,080 |
| 2021 | 8 | 360 | 450 | $72,883 | $29,533 |
| 2020 | 10 | 366 | 519 | $68,031 | $21,784 |
Total Patients
1,187
Total Services
1,524
Medicare Billing
$90,775
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 123 | 145 | $32,770 | $12,600 | 38.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 78 | $12,012 | $4,879 | 40.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $6,860 | $1,900 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 103 | 129 | $29,154 | $11,893 | 40.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 92 | $14,168 | $5,041 | 35.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $6,174 | $1,659 | 26.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 14 | 15 | $900.00 | $465.39 | 51.7% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 14 | 15 | $930.00 | $444.75 | 47.8% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 11 | 11 | $715.00 | $315.39 | 44.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 18 | 19 | $684.00 | $215.97 | 31.6% |
| 81002 | Urinalysis, manual test | Office | 2022 | 12 | 13 | $260.00 | $44.65 | 17.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 143 | 181 | $40,906 | $16,819 | 41.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 91 | 140 | $21,560 | $9,365 | 43.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $4,802 | $1,184 | 24.6% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 29 | 29 | $1,885 | $787.25 | 41.8% |
| 90756 | Vaccine for influenza derived from cell cultures for injection into muscle, quadrivalent, antibiotic free, 0.5ml dosage | Office | 2021 | 23 | 23 | $1,150 | $624.14 | 54.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 23 | 23 | $1,380 | $414.23 | 30.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 24 | 25 | $900.00 | $287.73 | 32.0% |
| 81002 | Urinalysis, manual test | Office | 2021 | 13 | 15 | $300.00 | $52.20 | 17.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 126 | 145 | $32,770 | $10,637 | 32.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 100 | 141 | $21,714 | $7,408 | 34.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 16 | 16 | $5,488 | $1,692 | 30.8% |
| 90756 | Vaccine for influenza for injection into muscle | Office | 2020 | 15 | 15 | $750.00 | $415.50 | 55.4% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 17 | 18 | $1,170 | $411.85 | 35.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 25 | 26 | $936.00 | $328.02 | 35.0% |
About Dr. Mark Dagdagan, M.D
Dr. Mark Dagdagan, M.D is a Family Medicine healthcare provider based in Bakersfield, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1831180587.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Dagdagan, M.D has received a total of $3,851 in payments from pharmaceutical and medical device companies, with $686.98 received in 2024. These payments were reported across 156 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,752).
As a Medicare-enrolled provider, Dagdagan has provided services to 1,187 Medicare beneficiaries, totaling 1,524 services with total Medicare billing of $90,775. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Bakersfield, CA
- Active Since 11/02/2005
- Last Updated 11/26/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1831180587
Products in Payments
- FARXIGA (Drug) $421.31
- Ozempic (Drug) $352.20
- ELIQUIS (Drug) $329.90
- ZENPEP (Drug) $208.98
- AREXVY (Drug) $201.36
- MYRBETRIQ (Drug) $177.75
- INJECTAFER (Drug) $157.53
- VRAYLAR (Drug) $146.88
- Tresiba (Drug) $140.92
- RYBELSUS (Drug) $117.43
- Rybelsus (Drug) $116.02
- ENTRESTO (Drug) $110.33
- PURAPLY WOUND MATRIX (Device) $104.01
- ANDEXXA (Biological) $103.88
- EUCRISA (Drug) $102.75
- CARDIOMEMS (Device) $94.81
- MOUNJARO (Drug) $90.15
- CONTOUR 3D (Device) $85.00
- BYDUREON (Drug) $79.68
- LINZESS (Drug) $71.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bakersfield
Mrs. Amira Ayad, M.d, M.D
Family Medicine — Payments: $278,616
Family Medicine $278,616
Matthew Beare, M.d, M.D
Family Medicine — Payments: $81,707
Family Medicine $81,707
Tien Nguyen, M.d, M.D
Family Medicine — Payments: $25,013
Family Medicine $25,013
Neha Chande, M.d., M.h.s, M.D., M.H.S
Family Medicine — Payments: $20,779
Family Medicine $20,779
John Heidrick, D.o, D.O
Family Medicine — Payments: $20,029
Family Medicine $20,029
Dr. Kamrun Naher, M.d, M.D
Family Medicine — Payments: $18,386
Family Medicine $18,386